Liquidity Rati

Current Ratio Particulars

Current Assets Current Liability Current Ratio 11223 5051 2.2

Year 2007- 2008

Zydus Sun
39372 6373 6.2

Cipla
37446 12878 2.9

Ranbax Glaxo y
65101 45883 1.4 14517 7302 2.0

Year 2
Zydus
15611 6915 2.3

Current Ratio by G

Analysis (Click Here)

Signi

This ratio is used to assess the firms ability to m Accounting principals, an ideal current ratio should b will be able to pay its current liabilities more easily. should at least twice

Quick Ratio Particulars

Quick Assets Quick Liability 6494 5051

Year 2007-2008
Zydus Sun
31644 6373 26242 12878 45458 45883

Ranbax Cipla Glaxo y

12189 7302

Year 2
Zydus
9599 6915

Quick Ratio

1.3

5.0

2.0

1.0

1.7

1.4

Quick Ratio by G

Analysis (Click Here)

Signi

This ratio is better test of short-term financial position in this we embody only those assets which can be eas supposed to be 1:1.If it more it will be considered to b of current liability there is at

Liquidity Ratio
Current Ratio

Year 2008-2009
Sun
42682 7198 5.9

Cipla
44179 14045 3.1

Ranbax Glaxo y
60085 41112 1.5 21826 6987 3.1

Year 2009-2010
Zydus Sun
17749 8661 2.0 37121 7579 4.9

Cipla
43673 12143 3.6

Ranbax Glaxo y
86931 41398 2.1 25096 8450 3.0

rrent Ratio by Graph

Significance

the firms ability to meet the short term obligations on time. According to urrent ratio should be 2:1.The higher the ratio the better it is because the firm abilities more easily. The reason behind this ratio is that our current liabilities should at least twice of our current liabilities.

Quick Ratio

Year 2008-2009
Sun
32925 7198 30196 14045 41678 41112

Ranbax Cipla Glaxo y

19254 6987

Year 2009-2010
Zydus Sun
10245 8661 26382 7579

Cipla
28548 12143

Ranbax Glaxo y
65005 41398 22240 8450

4.6

2.1

1.0

2.8

1.2

3.5

2.4

1.6

2.6

uick Ratio by Graph

Significance

erm financial position of the company in comparison with current ratio because ets which can be easily and readily converted into cash. An ideal Quick Ratio is ill be considered to be better. The idea behind this ratio is that for every rupee nt liability there is at least one rupee of liquid assets.

Special Working Note

Zydus values are in Millions Sun values are in Millions Cipla values are in rupees in crores Ranbaxy values are in Millions GSK values are in lakhs

Sto
Particulars Zydus
COGS Average Stock Ratio 8964 4312 2.1

Year 2007-2008
Sun
8855 7186 1.2

Cipla
22110 10490 2.1

Ranba xy
33588 18025 1.9

Analysis (Click Here)

This ratio indicates whether our stock is usi number of times the stock in hand is turned

Deb
Particulars Zydus
Credit Sales Average Debtors Ratio 22660 3169 51 7.2

Year 2007-2008
Sun
33565 10482 114 3.2

Cipla
40103 12170 111 3.3

Ranba xy
72555 13323 67 5.4

Analysis (Click Here)

This ratio shows the speed with which the am from debtors is collecting more frequently. T bear less expen

Aver
Particulars Zydus
Average debtors Credit Sales per day Ratio 3169 62 51.1

Year 2007-2008
Sun
10482 91 115.2

Cipla
1217 10 121.7

Ranba xy
15323 191 80.2

Col
2007-2008
Zydus Sun Cipla Ranbaxy GSK

Analysis (Click Here)

This ratio shows the time in which the cus debtors which increases the chances of b

Analysis (Click Here)

This ratio shows the time in which the cus debtors which increases the chances of b

Cred
Particulars Zydus
Credit Purchases Average Creditors Ratio 6559 3742 208 1.8

Year 2007-2008
Sun
8412 1948 85 4.3

Cipla
21960 4190 70 5.2

Ranba xy
33663 9900 107 3.4

Credito

Analysis (Click Here)

This ratio indicates the speed whether the creditors are being paid more frequently. It w

Fix
Particulars Zydus
Sales Fixed Assets 23638 14001

Year 2007-2008
Sun
34605 11039

Cipla
4104 1894

Ranba xy
68256 42045

Ratio

1.7

3.1

2.2

1.6

Analysis (Click Here)

This ratio is of importance in manufacturing assets are being utilized. The higher t

Work

Particulars Zydus
COGS Working Capital Ratio 23638 6172 3.8

Year 2007-2008
Sun
34605 32999 1.0

Cipla
4104 2456 1.7

Ranba xy
68256 23432 2.9

Work

Analysis (Click Here)

This ratio reveals how effectively current a indust

Activity Ratio
Stock Turnover Ratio Year 2008-2009
Glaxo
7060 2220 3.2

008
Zydus
10708 5370 2.0

Sun
10883 8742 1.2

Cipla
25280 12590 2.0

Ranbax y
34187 19025 1.8

Glaxo
7586 2451 3.1

Ratio by Graph

Significance

icates whether our stock is using efficiently or not. This ratio shows the speed with which the stock is rotat mes the stock in hand is turned into sales during the year. The higher the ratio the better it is because it indicate in huge amount

Debtors Turnover Ratio Year 2008-2009

Glaxo
16934 479 10 35.4

008
Zydus
28624 4200 54 6.8

Sun
42723 11493 98 3.7

Cipla
49606 16290 120 3.0

Ranbax y
73441 15854 79 4.6

Glaxo
19077 558 11 34.2

Debtors Ratio by Graph

Significance

ws the speed with which the amount is collected from debtors. The higher the ratio the better it is because it in s collecting more frequently. The more quickly the debtors pay in an organization , the firm is less risky from ba bear less expense on money collection and it will also increase the liquidity of the firm.

Average collection period Year 2008-2009

Glaxo
4910 440 11.2

008
Zydus
4200 78 53.8

Sun
11493 117 98.2

Cipla
1629 13 125.3

Ranbax y
14120 203 69.6

Glaxo
4785 463 10.3

Collection period by Graph

2008-2009
GSK Zydus Sun Cipla Ranbaxy GSK Zydus

baxy

Significance

hows the time in which the customers are paying for credit sales. Increase in this ratio implies that excessive blo hich increases the chances of bad debts on the other hand, if there is decrease in collection period it indicates t increase.

Creditors Turnover Ratio Year 2008-2009

Glaxo
6580 2417 134 2.7

008
Zydus
10239 4448 159 2.3

Sun
10594 2468 85 4.3

Cipla
26250 4950 69 5.3

Ranbax y
31149 12716 149 2.4

Glaxo
7351 2747 136 2.7

Creditors Turnover Ratio by Graph

Significance

dicates the speed whether the firm is able to pay its creditors or not. The higher the ratio the better it is becau eing paid more frequently. It will create Brand Equity of any firm and will enhance the satisfaction among the s

Fixed Turnover Ratio Year 2008-2009

Glaxo
174808 9292

008
Zydus
29171 17187

Sun
43750 16196

Cipla
5021 2358

Ranbax y
74449 49607

Glaxo
178699 10037

18.8

1.7

2.7

2.1

1.5

17.8

Fixed Ratio by Graph

Significance

of importance in manufacturing concerns where investment in fixed assets is quiet high. This ratio denotes how are being utilized. The higher the ratio the better it is because it will show that the fixed assets are utilizing mor

Working Capital Turnover Ratio

008
Glaxo
174808 138663 1.3

Year 2008-2009
Zydus
29171 8696 3.4

Sun
43750 35484 1.2

Cipla
5021 3013 1.7

Ranbax y
74449 19217 3.9

Glaxo
178699 158117 1.1

Working Capital Ratio by Graph

Significance

veals how effectively current assets or working capital has been utilized in making sales. This ratio is useful in n industries where current assets play a major role in generating sales.

Year 2009-2010
Zydus
13249 6758 2.0

Sun
13581 10247 1.3

Cipla
26280 14550 1.8

Ranba xy
33846 20166 1.7

Glaxo
8513 2714 3.1

which the stock is rotated into sales or the better it is because it indicates that our selling is

Year 2009-2010
Zydus
35741 4609 47 7.8

Sun
39039 10279 96 3.8

Cipla
53595 17100 116 3.1

Ranba xy
85506 17225 74 5.0

Glaxo
21510 504 9 42.7

the better it is because it indicates that amount the firm is less risky from bad-debts so it has to iquidity of the firm.

Year 2009-2010
Zydus
4609 97 47.5

Sun
10279 106 97.0

Cipla
1709 14 122.1

Ranba xy
15852 208 76.2

Glaxo
5583 522 10.7

2009-2010
Zydus Sun Cipla Ranbaxy GSK

tio implies that excessive blocks of funds with ollection period it indicates that liquidity will

Year 2009-2010
Zydus
12502 5700 166 2.2

Sun
11927 2475 76 4.8

Cipla
25680 7810 111 3.3

Ranba xy
34432 16684 177 2.1

Glaxo
8080 3144 142 2.6

e ratio the better it is because it will show the the satisfaction among the suppliers or creditors.

2009-2010
Zydus
36142 19326

Sun
39814 16776

Cipla
5411 2695

Ranba xy
76117 51135

Glaxo
195039 11418

1.9

2.4

2.0

1.5

17.1

high. This ratio denotes how efficiently the fixed fixed assets are utilizing more effectively.

Year 2009-2010
Zydus
36142 9088 4.0

Sun
39814 29541 1.3

Cipla
5411 3152 1.7

Ranba xy
76117 18973 4.0

Glaxo
195039 179151 1.1

sales. This ratio is useful in non-manufacturing ting sales.

Leverage Ra
Year 2007-2008
Zydus
Debt Equity Ratio 8277 10622 0.8

Debt Rati
Particulars

Sun
1436 49914 0.0

Cipla
5405 37551 0.1

Ranbax Glaxo y
42848 43962 1.0 13866 13808 1.0

Year 20
Zydus
12674 12352 1.0

Debt Ratio By G
2007-2008
Zydus Ranbaxy Sun GSK Cipla

20

Zydus Ranbaxy

Analysis (Click Here)

Signi

This ratio is calculated to assess the ability of the firm is 2:1 then it is considered as safe. If the Debt- equity r long term view. A high debt-equity ratio is a danger si protection to l

Debt-Total Fund
Particulars Zydus
Debt Total Fund 8377 18999

Year 2007-2008
Sun
1436 51350

Cipla
540 4295

Ranbax Glaxo y
41415 69437 138663 276747

Year 20
Zydus
12674 25026

Ratio

0.4

0.0

0.1

0.6

0.5

0.5

Debt -Total fund Ratio

Analysis (Click Here)

Signi

Generally 67% or 0.67:1 debt to total fund ratio is the than 0.67 then we will consider as a risky organizatio Debt- Total fund ratio is lower than 0.6

Proprietary R
Particulars Zydus
Equity Total Assets Ratio 10622 25478 0.4

Year 2007-2008
Sun
49914 59701 0.8 3755 5732 0.7 28022 92778 0.3

Ranbax Cipla Glaxo y

138083 200595 0.7

Year 20
Zydus
12352 33485 0.4

Proprietary Ratio b

Analysis (Click Here)

Signi

A higher proprietary ratio is generally an indicato because it means that a large proportion of total asse external sou

Leverage Ratio
Debt Ratio Year 2008-2009
Sun
1788 70449 0.0

Cipla
9402 43478 0.2

Ranbax Glaxo y
36295 43433 0.8 15811 15755 1.0

Year 2009-2010
Zydus
10905 16285 0.7

Sun
1711 78289 0.0

Cipla
50 59105 0.0

Ranbax y
43348 56047 0.8

Debt Ratio By Graph

2008-2009
Zydus Ranbaxy Sun GSK Cipla Zydus Ranbaxy

2009-2010
Sun GSK Cipla

Significance

s the ability of the firm to meet its long term liabilities. When Debt-Equity ratio fe. If the Debt- equity ratio is more than it show a risky financial position from the uity ratio is a danger signal for long term lenders. Lower than 2:1 ratio will show protection to long term lenders

bt-Total Fund Ratio Year 2008-2009

Sun
1788 72238

Cipla
940 5288

Ranbax Glaxo y
42848 85811 158117 315670

2009-2010
Zydus
10905 27190

Sun
1711 81712

Cipla
5 5915

Ranbax y
36295 76729

0.0

0.2

0.5

0.5

0.4

0.0

0.0

0.5

-Total fund Ratio by Graph

Significance

o total fund ratio is the satisfactory or ideal.If the debt- total fund ratio is greater r as a risky organization because firm is taking outside loans for its existence. If ratio is lower than 0.67 then we will consider as a protected firm

Proprietary Ratio Year 2008-2009

Sun
70749 80727 0.9 4347 6856 0.6 42962

Ranbax Cipla Glaxo y

158117 228163 0.7 120139 0.4

Year 2009-2010
Zydus
16285 37384 0.4

Sun
78289 88621 0.9

Cipla
5910 7309 0.8

Ranbax y
43433 116629 0.4

oprietary Ratio by graph

Significance

s generally an indicator of sound financial position from long term point of view proportion of total assets is provided by equity and the firm is less dependent on external sources of finance.

2010
Glaxo
17915 17860 1.0

010
Cipla

10
Glaxo
179151 357760

0.5

2010
Glaxo
179151 244532 0.7

Profitability Ratio

Gross Profit
Particulars Zydus
Gross Profit Net Sales Ratio 14674 22660 64.8

Year 2007-2008
Sun
25841 33565 77.0 1892 4010 47.2 40108 69822 57.4

Ranbax Cipla Glaxo y

104268 160820 64.8

Year 20
Zydus
18463 28624 64.5

Gross Profit B

Analysis (Click Here)

Zydus
Credit Sales 22660

Signif

There is no ideal ratio or no any s because this ratio measures the m

Sun
33565

Cipla
40103

Ranbax Glaxo y
72555 16934

Zydus
28624

Net-Profit
Particulars Zydus
Net profit 2794

Year 2007-2008
Sun
14869

Cipla
10910

Ranbax Glaxo y
-9512 5911

Year 20
Zydus
4161

Sales Ratio

22660 12.3

33565 44.3

40103 27.2

72555 -13.1

16934 34.9

28624 14.5

Net-Profit Ratio

Analysis (Click Here)

Signif

This is the accurate measurement of firms profitability the indirect/operational expenses from gross profit. Th

Profitability Ratio on Sales:-

Gross Profit Ratio Year 2008-2009

Sun
32865 42723 76.9 2006 4960 40.4 41116 74139 55.5

Ranba Cipla Glaxo xy

105629 169340 62.4

Year 2009-2010
Zydus
22893 35741 64.1

Sun
26253 39039 67.2

Cipla
2783 5359 51.9

Ranbax y
41255 75970 54.3

Gross Profit By Graph

Significance

no ideal ratio or no any standard for this ratio, the higher the ratio the better it is his ratio measures the margin of profit available on sales.

Sun
42723

Cipla
49606

Ranba Glaxo xy
73441 19077

Zydus
35741

Sun
39039

Cipla
53595

Ranbax y
85506

Net-Profit Ratio Year 2008-2009

Sun
18177

Cipla
12802

Ranba Glaxo xy
2964 5079

Year 2009-2010
Zydus
6755

Sun
13510

Cipla
20309

Ranbax y
14968

42723 42.5

49606 25.8

73441 4.0

19077 26.6

35741 18.9

39039 34.6

53595 37.9

85506 17.5

Net-Profit Ratio By Graph

Significance

nt of firms profitability because in this ratio we take net profit after deducting all es from gross profit. The higher the ratio the more good condition the firm is in.

2010
Glaxo
116710 190776 61.2

Glaxo
21510

2010
Glaxo
5605

21510 26.1

Profitability Ratio

Return on Share
Particulars Zydus
PAIT Equity Ratio 2621 10622 0.2

Year 2007-2008
Sun
15509 49914 0.3

Cipla
701 3755 0.2

Ranba Glaxo xy
7867 40667 28022 0.3 138083 0.3

Year 20
Zydus
3032 12352 0.2

Shareholder Fund
2007-2008
Zydus Ranbaxy Sun GSK Cipla Zydus Ranbaxy

200

Analysis (Click Here)

Signi

This ratio reveals that how effectively the firm is using i competitors then we can take decisions that

Earning Pe
Particulars Zydus
PAT Shares 2576 125

Year 2007-2008
Sun
15509 207

Cipla
701 77

Ranba Glaxo xy
7745 373 40960 847

Year 20
Zydus
3031 136

Ratio

20.6

74.9

9.1

20.8

48.4

22.3

Earning Per Sha

Analysis (Click Here)

Signi

It is the accurate measurement of the profit available the ratio the more sharehol

Profitability Ratio on Investment

turn on Share holder fund Year 2008-2009

Sun
18780 70449 0.3

Cipla
771 4347 0.2

Ranba Glaxo xy
-9349 46287 42962 -0.2 157553 0.3

Year 2009-2010
Zydus
5298 16285 0.3

Sun
13469 78289 0.2

Cipla
1082 5910 0.2

Ranbax y
3106 43433 0.1

areholder Fund Ratio By Graph

2008-2009
Zydus Ranbaxy Sun GSK Cipla

2009-2010
Zydus Ranbaxy Sun GSK Cipla

Significance

tively the firm is using its proprietary fund. When we compare this ratio with other an take decisions that which firm has more strength on its financial side

Earning Per Share Year 2008-2009

Sun
18177 207

Cipla
771 77

Ranba Glaxo xy
-9512 420 46287 847

Year 2009-2010
Zydus
5051 136

Sun
13469 207

Cipla
1082 77

Ranbax y
2964 420

87.8

10.0

-22.6

54.6

37.1

65.1

14.1

7.1

Earning Per Share By Graph

Significance

of the profit available to the equity shareholders on a per share basis. The more atio the more shareholders retention will be received.

2010
Glaxo
50046 178609 0.3

0
Cipla

2010
Glaxo
50046 847

59.1